Stay updated on Pembrolizumab with Lenvatinib in Urothelial Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with Lenvatinib in Urothelial Carcinoma Clinical Trial page.

Latest updates to the Pembrolizumab with Lenvatinib in Urothelial Carcinoma Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check15 days agoChange DetectedAn entry 'Revision: v3.6.6' was added to the study's history page. The previous 'Revision: v3.6.5' entry and the 'References' section were removed, reflecting an update to the record's version history.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check36 days agoChange DetectedThe history list shows the page revision updated from v3.6.4 to v3.6.5, indicating a new version of the page. The update is limited to the version label and does not affect content.SummaryDifference0.0%

- Check50 days agoChange DetectedA new revision entry, Revision: v3.6.4, was added to the history. The previous Revision: v3.6.3 entry was removed.SummaryDifference0.0%

- Check72 days agoChange DetectedThe page history revision label advanced from v3.6.2 to v3.6.3, indicating a new version of the page has been released.SummaryDifference0.0%

- Check79 days agoChange DetectedA new revision entry, Revision: v3.6.2, has been added to the Study Record History, replacing Revision: v3.6.0. This indicates a minor platform update to the history view.SummaryDifference0.0%

- Check93 days agoChange DetectedThe study page now shows that recruitment has ceased. The page revision is updated to v3.6.0, replacing the previous version.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab with Lenvatinib in Urothelial Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Lenvatinib in Urothelial Carcinoma Clinical Trial page.